GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CardioComm Solutions Inc (OTCPK:EKGGF) » Definitions » Capex-to-Revenue

EKGGF (CardioComm Solutions) Capex-to-Revenue : 0.00 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is CardioComm Solutions Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

CardioComm Solutions's Capital Expenditure for the three months ended in Sep. 2024 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was $0.10 Mil.

Hence, CardioComm Solutions's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.00.


CardioComm Solutions Capex-to-Revenue Historical Data

The historical data trend for CardioComm Solutions's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioComm Solutions Capex-to-Revenue Chart

CardioComm Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 - 0.01 -

CardioComm Solutions Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioComm Solutions's Capex-to-Revenue

For the Health Information Services subindustry, CardioComm Solutions's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioComm Solutions's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where CardioComm Solutions's Capex-to-Revenue falls into.



CardioComm Solutions Capex-to-Revenue Calculation

CardioComm Solutions's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.001) / 0.653
=0.00

CardioComm Solutions's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.103
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions  (OTCPK:EKGGF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


CardioComm Solutions Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of CardioComm Solutions's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioComm Solutions Business Description

Traded in Other Exchanges
Address
18 Wynford Drive, Suite 305, North York, ON, CAN, M3C 3S2
CardioComm Solutions Inc develops advanced software, hardware and core laboratory reading services related to the electrocardiogram ("ECG") and ambulatory arrhythmia monitoring systems for medical and consumer markets. It engages in the provision of management software solutions. It specializes in software engineering of computer-based electrocardiogram management and reporting software. The company's products include software, Gems Win, Global ECG Management System, GlobalCardio 12 lead; hardware, include handheld ECG monitor; Asp Services, include ECG management service and smart monitoring; software modules, consists of Win Air, Auto attendant, HL7 interface and EMR integration; and other products, include ECG viewer SDK and QRS 12 lead universal.